About Kritika Sarmah
Her interest in risky instruments and passion for writing made Kritika an analyst and financial journalist.
She earned her bachelor's degree in commerce and is currently pursuing the CFA program.
With her fundamental approach, she aims to help investors identify untapped investment opportunities.
Recent Articles By Kritika Sarmah
3 Retail Stocks to Buy Now for Steady Returns
With a surge in U.S. retail sales, especially online, and a promising outlook driven by rising personal income and the sector's technological advancements, fundamentally strong retail stocks Tesco (TSCDY), Target (TGT), and Village Super Market (VLGEA) might offer solid returns. Read on...
Which Auto Stock Presents Better Value for Investors? Tesla (TSLA) vs. Oshkosh (OSK)
The auto sector seems poised for growth this year, fuelled by robust demand and government inititatives. So, let us analyze leading auto stocks Tesla (TSLA) and Oshkosh (OSK) to determine which one offers value investment...
3 Tech Stocks on the Verge of Major Gains
In the fast-paced world of tech, demand is booming for innovative solutions and cutting-edge hardware. This sets the perfect stage for tech powerhouses Nokia (NOK), Dolby Laboratories (DLB), and Indra Sistemas (ISMAY) to ride the wave and seize growth opportunities in this dynamic industry. Keep reading...
Is Visa (V) or Nu (NU) the Best Finacial Stock to Own?
Amidst high interest rates and a thriving consumer finance sector, let's analyze leading financial stocks Visa (V) and Nu Holdings (NU) to determine which has superior investment potential...
3 Tech Stocks Ripe for May Investment
With the worldwide IT spending estimated to surge over $5 trillion this year, the tech sector continues its robust expansion. So, investors might consider investing in fundamentally solid tech stocks HP Inc. (HPQ), Proto Labs (PRLB), and Hackett Group (HCKT) this month. Read more...
Should Long-Term Investors Chase GameStop (GME) or Upbound (UPBD)?
Amidst robust consumer spending, evolving customer tastes, and rapid digitalization, the specialty retail industry emerges as a hotbed for substantial growth. Now, let's turn our attention to leading specialty retail stocks, GameStop (GME) and Upbound Group (UPBD), dissecting their potential to uncover which of them is the better long-term investment...
Apple (AAPL) Quarterly Earnings Update: Buy or Wait?
Tech giant Apple (AAPL) has released its first-quarter earnings, revealing record-high services revenue. However, concerns arise from shortcomings in its wearables segments and delayed entry into the generative AI space. Let's analyze AAPL's recent performance, assess key fundamentals, and decide whether to buy or wait on the stock...
Strategies for Capitalizing on Advanced Micro Devices (AMD) Earnings Momentum
Despite an impressive first quarter earnings report, shares of Advanced Micro Devices (AMD) are in a downward spiral. Let's delve into the intricacies of AMD's current market dynamics to uncover the underlying reasons behind this unexpected turn of events...
Buy Alert: 3 Pharma Stocks Under $20 to Invest in Now
With rising medicine demand and drug shortages in the U.S., pharmaceutical stocks under $20 present lucrative opportunities for investors, promising substantial returns in a ripe market. So, I think fundamentally solid pharma stocks ACADIA Pharmaceuticals (ACAD), Amneal Pharmaceuticals (AMRX), and OptiNose (OPTN), which are currently trading under $20, could be ideal investments now. Keep reading...